Aethlon Medical, Inc. (OTCMKTS:AEMD) released its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported ($0.14) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.16) by $0.02, Bloomberg Earnings reports.
Aethlon Medical (OTCMKTS:AEMD) opened at $0.89 on Monday. Aethlon Medical has a 52 week low of $0.79 and a 52 week high of $5.17.
ILLEGAL ACTIVITY WARNING: “Aethlon Medical, Inc. (OTCMKTS:AEMD) Releases Earnings Results, Beats Expectations By $0.02 EPS” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US and international copyright and trademark laws. The correct version of this piece of content can be read at https://ledgergazette.com/2017/11/13/aethlon-medical-inc-aemd-issues-quarterly-earnings-results.html.
Separately, ValuEngine raised Aethlon Medical from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.
Aethlon Medical Company Profile
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.